Forus Health, best known for its 3nethra series of eye screening devices, has screened over 22 million patients across 75 countries.
Revenue for the quarter stood at ₹782 crore, up from ₹738 crore in Q1. EBITDA margins improved to 20.5%, up from 13.7% in the previous quarter.
The Indian hospital chain, known for its low-cost, high-throughput model, is entering the UK market through its Cayman Islands subsidiary, acquiring the secondary care division of Practice Plus Group — the fifth-largest private healthcare network in the UK and fourth-largest NHS service provider.
Tata Consumer's total income, including other income, stood at Rs 5,003.91 crore, up 17.45 per cent.
Shiprocket, Meesho, Skyways Air Services among 7 firms to receive SEBI nod to float IPO
The company's consolidated revenue from operations rose 25 percent at Rs 9,129.73 crore second quarter of the current fiscal.
Tata Consumer Q2 results: Revenue increases 18% to Rs 4,966 crore
Bharti Airtel is likely to report a steady Q2 while Tata Consumer will see marginal profit growth, say analysts; Titan is expected to post double-digit revenue growth, led by pricing gains in gold, said a brokerage
Pine Labs IPO: The public issue includes a fresh issue worth Rs 2,080 crore and an offer-for-sale of 8.23 crore shares by existing shareholders.
In the mainboard segment, Orkla India will make its market debut on November 6, followed by Studds Accessories on November 7 and Lenskart Solutions on November 10.
Netweb Technologies' revenue from operations rose 20.9 percent to Rs 303.7 crore in Q2 FY26, from Rs 251 crore in Q2 FY25.
In a complaint registered by Mumbai’s Economic Offences Wing (EOW) on October 30, Tiwari accused directors from Creaegis, Healthquad, and Ackerman Van Haaren of diverting company funds to non-existent entities
The company will use funds for investment in its subsidiaries such as Qwikcilver Singapore, Pine Payment Solutions, Malaysia, and Pine Labs UAE for expanding the presence outside the country
Shadowfax IPO | The company proposed to issue fresh shares worth Rs 1,000 crore, while investors and others will be selling their shares worth Rs 1,000 crore via offer-for-sale.
Tenneco Clean Air IPO | The company has filed the draft document with the SEBI for its Rs 3,000-crore IPO on June 30 this year, while the capital markets regulator approved the said public issue on October 03.
Safecure Services IPO | The company is raising Rs 30.6 crore via initial public offering (IPO) of 30 lakh shares at Rs 102 per share.
Curis Lifesciences IPO | The company aims to raise Rs 27.52 crore via public issue of 21.5 lakh shares at the upper price band. This is purely a fresh issue by the company with no offer-for sale component.
Revenue from operations rose to Rs 35,031 crore from Rs 32,930.72 crore in July-September 2024.
Unlike competitors that rushed to market, Lupin spent its early years conducting trials and publishing peer-reviewed studies — a strategy that CEO Sidharth Srinivasan says has been key to survival.
Global PMI data indicate stabilising manufacturing and strong services momentum, while India’s factory activity remains robust. The BoE is expected to hold rates steady, and India’s forex reserves continue rising
The total income of the company in the July-September period rose to Rs 40,464 crore over Rs 38,934 crore in the year-ago period, according to an exchange filing.
The acquisition gives Narayana Hrudayalaya a strategic entry into the mature UK healthcare market, which is witnessing a shift toward day-care procedures and increased private-pay penetration.
The company's total revenue from operations increased 13 percent to Rs 42,101-crore in the September quarter as compared with Rs 37,203 crore in the year-ago period.
The latest funding round valued the startup at Rs 1,000 crore and saw participation from prominent angel investors including Vikram Chatwal (MediAssist), Dharmil Sheth and Hardik Dedhia (PharmEasy), and Salil Musale (Astarc Ventures).
Lenskart Solutions IPO | The Gurugram-based eyewear products company is issuing fresh shares worth Rs 2,150 crore, while promoters and investors will be selling 12.75 crore shares worth Rs 5,128 crore via offer-for-sale route.